|
|
|
|
The PDZ-Binding Motif of Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Is a Determinant of Viral Pathogenesis
|
|
|
|
|
|
|
|
نویسنده
|
jimenez-guardeño j.m. ,nieto-torres j.l. ,dediego m.l. ,regla-nava j.a. ,fernandez-delgado r. ,castaño-rodriguez c. ,enjuanes l.
|
|
منبع
|
plos pathogens - 2014 - دوره : 10 - شماره : 8
|
|
چکیده
|
A recombinant severe acute respiratory syndrome coronavirus (sars-cov) lacking the envelope (e) protein is attenuated in vivo. here we report that e protein pdz-binding motif (pbm),a domain involved in protein-protein interactions,is a major determinant of virulence. elimination of sars-cov e protein pbm by using reverse genetics caused a reduction in the deleterious exacerbation of the immune response triggered during infection with the parental virus and virus attenuation. cellular protein syntenin was identified to bind the e protein pbm during sars-cov infection by using three complementary strategies,yeast two-hybrid,reciprocal coimmunoprecipitation and confocal microscopy assays. syntenin redistributed from the nucleus to the cell cytoplasm during infection with viruses containing the e protein pbm,activating p38 mapk and leading to the overexpression of inflammatory cytokines. silencing of syntenin using sirnas led to a decrease in p38 mapk activation in sars-cov infected cells,further reinforcing their functional relationship. active p38 mapk was reduced in lungs of mice infected with sars-covs lacking e protein pbm as compared with the parental virus,leading to a decreased expression of inflammatory cytokines and to virus attenuation. interestingly,administration of a p38 mapk inhibitor led to an increase in mice survival after infection with sars-cov,confirming the relevance of this pathway in sars-cov virulence. therefore,the e protein pbm is a virulence domain that activates immunopathology most likely by using syntenin as a mediator of p38 mapk induced inflammation. © 2014 jimenez-guardeño et al.
|
|
|
|
|
آدرس
|
department of molecular and cell biology,centro nacional de biotecnología (cnb-csic),darwin 3,campus universidad autónoma de madrid,madrid, Spain, department of molecular and cell biology,centro nacional de biotecnología (cnb-csic),darwin 3,campus universidad autónoma de madrid,madrid, Spain, department of molecular and cell biology,centro nacional de biotecnología (cnb-csic),darwin 3,campus universidad autónoma de madrid,madrid,spain,david h. smith center for vaccine biology and immunology,university of rochester medical center,rochester,ny, United States, department of molecular and cell biology,centro nacional de biotecnología (cnb-csic),darwin 3,campus universidad autónoma de madrid,madrid, Spain, department of molecular and cell biology,centro nacional de biotecnología (cnb-csic),darwin 3,campus universidad autónoma de madrid,madrid, Spain, department of molecular and cell biology,centro nacional de biotecnología (cnb-csic),darwin 3,campus universidad autónoma de madrid,madrid, Spain, department of molecular and cell biology,centro nacional de biotecnología (cnb-csic),darwin 3,campus universidad autónoma de madrid,madrid, Spain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|